1. Mistry N, Tolani M, Dholakia Y. New drugs for tuberculosis. Prous Thompson 2015, 40: 39-56. Review.
  2. Bhatter P, Gupta P, Daswani P, Tetali P, Birdi T. Anti mycobacterial efficacy of Andrographis  paniculata  Nees. leaf extracts under intracellular and hypoxic conditions.  J Evid Based Complementary Altern Med, 2015, 20 :3-8
  3. Bhatter P, Chatterjee A, Mistry NF. Kinetics of recA and recX induction in drug susceptible and MDR clinical strains of Mycobacterium tuberculosis. J Antimicrob Chemother, 2014, e Pub: 1-4.
  4. Gupta P, Bhatter P, D’Souza D, Tolani MP, Daswani P,  Tetali P,  Birdi T. Evaluating the anti Mycobacterium tuberculosis activity of Alpinia galangal (L.) Wild. Axenically under reducing oxygen conditions and intracellular assays. BMC Complementary & Alternative Medicine, 2014, 14: 84.
  5. Bhatter P and Mistry NF. Fitness of acquired drug resistant M. tuberculosis isolates from DOTS compliant patients.Tuberculosis, 2013, 93: 418-424.
  6. Chatterjee A, Saranath D, Bhatter P, Mistry NF. Global transcriptional profiling of longitudinal clinical isolates of Mycobacterium tuberculosis exhibiting rapid accumulation of drug resistance. PLOS ONE, 2013, 8: e54717.
  7. Chatterjee A, Mistry NF. MIRU-VNTR profiles of three major Mycobacterium tuberculosis spoligotypes found in Western India. Tuberculosis, 2013; 93: 250-256.
  8. Birdi T,   D’Souza  D, Tolani M,  Daswani P,   Nair V,  Tetali P, Toro JC,   Hoffner S. Assessment  of   the  activity  of  selected  Indian  medicinal   plants against Mycobacterium  tuberculosis :  A preliminary  screening using  the  Microplate Aalmar  Blue  Assay.  Eur J Med Plants, 2012, 2: 308-323.
  9. Mistry NF, Tolani MP, Osrin D. Drug resistant tuberculosis in Mumbai, India: An agenda for operations research. Operations Research for healthcare, 2012, 1: 45-53.
  10. Bhatter P, Chatterjee A, Mistry NF. The dragon and the tiger: Realities in the control of Tuberculosis.  Interdiscip Perspect Infect Dis, 2012, 2012: 1-10.
  11. Bhatter P, Chatterjee A, D’Souza D, Tolani MP, Mistry NF. Estimating strains fitness by competition assays between drug susceptible and resistance Mycobacterium tuberculosis of predominant lineages in Mumbai, India. PLoS one, 2012, 7:  e33507.
  12. Tolani MP, D’Souza D, Mistry NF. Drug resistance mutation and heteroresistance detected using the Geno Type MTBDR plus assay and their implication for treatment outcomes in patients from Mumbai, India. BMC Infect Dis, 2012, 12: 9.
  13. Bhatter P, Chatterjee A, Mistry N. Mycobacterium tuberculosis Beijing epidemics: A race against mutations. Tuberculosis, 2012, 92: 92-94.
  14. Dholakia YN, D’Souza D, Tolani MP, Chatterjee A, Mistry NF. Chest X-rays and associated clinical parameters in pulmonary Tuberculosis cases from national tuberculosis programme, Mumbai. Infect  Dis Rept, 2012, 4: 30-34.
  15. Dholakia Y, Quazi Z, Mistry N. Drug resistant tuberculosis: Study of clinical practices of chest physicians Maharashtra, India. Lung India, 2011, 29: 30-35.
  16. Atre SR, D’Souza D, Vira T, Chatterjee A, Mistry N. Risk factors associated with MDR-TB at the onset of therapy among new cases registered with the RNTCP in Mumbai, India. Indian J Public Health, 2011, 55: 14-21.
  17. Chatterjee A, D'Souza D, Vira T, Bamne A, Ambe GT, Nicol  P, Wilkinson RJ,  Mistry N. Strains of Mycobacterium tuberculosis from Western Maharashtra, India exhibit a high degree of diversity and strain-specific associations with drug resistance, cavitary disease and treatment failure. J Clin Microbiol, 2010, 48: 3593-3599.
  18. D’souza D, Mistry NF, Vira T, Dholakia Y, Hoffner S, Pasvol G, Nicol M, Wilkinson R. High levels of Multidrug Resistant Tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an Urban metropolis (Mumbai) in Western India. BMC Public Health, 2009, 9: 211.
  19. Atre SR, D’Souza D, Dholakia Y, Mistry NF. Observations on categorization of new TB Cases: Implications for controlling drug resistance. Int J Tuber Lung Dis, 2007, 11: 1152-1153.
  20. Mistry NF, Dholakia Y, D’Souza D, Taylor M, Hoffner S, Birdi TJ. Rhodococcus and Mycobacterium tuberculosis-Masquerade or mixed infection. Int J Tuberc Lung Dis, 2006, 10: 351-353.
  21. Atre S.R, Mistry NF. Multidrug- resistant tuberculosis (MDR-TB) in India: An attempt to link biosocial determinants. J Public Health Policy, 2005,  26: 96-114.
  22. D’souza D, Birdi TB, Dholakia Y, Hira S, Antia NH. Importance of blood samples for diagnosis and drug sensitivity testing in HIV positive patients with suspected Tuberculosis. Indian J Tuberculosis, 2004, 51:77-81.
  23. Mistry NF, Iyer A, D'Souza D, Taylor GM, Young D, Antia NH. Spoligotyping of Mycobacterium tuberculosis isolates from multiple drug resistant tuberculosis patients from Bombay, India. J Clin Microbiol, 2002, 40: 2677-2680.
  24. Mistry NF, Antia NH. Controlling MDR-TB: An agenda beyond drugs In: Health and Equity - Effecting Change. Ed. Shobha Raghuram. HIVOS, Netherlands Technical Report Series 1.8. 2000, 95-102.
  25. Sethna KB, Mistry NF, Dholakia Y, Antia NH, Harboe M. Longitudinal trends in serum levels of mycobacterial secretory (30 kD) and cytoplasmic (65 kD) antigens during chemotherapy of pulmonary tuberculosis patients. Scand J Infect Dis, 1998, 30: 363-369.
  26. Basu A, Mistry NF, Antia NH. Views on the sustenance of resistant Mycobacterium tuberculosis in the environment. Medical Hypothesis, 1995, 45: 421-426.

© 2015 Foundation for Medical Research | Contact Us

Site Design Mihika Shilpi